Home›Companies›Biotech & Pharma›ViroMissile

ViroMissile, Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 6, 2025·Suggest an edit

About ViroMissile

ViroMissile is a private company based in LA Jolla, California. It has reported $550,000 raised in two offerings on Form D since April 2023. Its chief executive is Nanhai Chen.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 12, 2025Mar 19, 2025amended Jun 6, 2025$500,000of $15.0M target5$100KEquity, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Apr 18, 2023Apr 26, 2023$50,000of $1.0M target1$50,000Equity, DebtRule 506(b)Form D ↗
Total, two offerings$550,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ViroMissile's Form D filed Jun 6, 2025.

RB
DW
Douglas Wall
Director
MB
Mark Bertagnolli
Executive officer and director
NC
Nanhai Chen
Chief Executive Officer and director
TZ
Tianyu Zhou
Director

Earlier filings also listed Weili Zhou (director, last listed Apr 2023).

Sources

  1. SECViroMissile, Inc. Form D/A, filed Apr 22, 2025
  2. SECViroMissile, Inc. Form D, filed Mar 19, 2025
  3. SECViroMissile, Inc. filing history